Sign in
health 3h ago

79-Year-Old Patient Receives Unapproved Experimental Weight Loss Drug Amid Trump Speculation

79-Year-Old Patient Receives Unapproved Experimental Weight Loss Drug Amid Trump Speculation

A patient aged 79 received an unapproved experimental weight loss drug, raising questions about access and regulatory oversight. The case has sparked widespread speculation linking the individual to former President Trump. Next, authorities may investigate the drug's distribution process and approval status.

Cronología · 8h ago

6h ago

1 article · Gizmodo

10h ago

1 article · Ars Technica Health

12h ago

1 article · Raw Story

0 Comments

Sign in to join the discussion

No comments yet

Be the first to share your thoughts

More health Stories